CRH (CRH) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
Achieved record Q2 2026 results with revenues of $10.8 billion, up 6% year-over-year, driven by strong demand, positive pricing, disciplined execution, and contributions from acquisitions.
Net income rose 13% to $1.5 billion, supported by operating performance and divestiture gains.
Completed 17 acquisitions YTD ($1.4 billion), including a definitive agreement to acquire Arcosa for $8.5 billion, reinforcing North American aggregates and infrastructure leadership.
Executed major divestitures totaling $1.9 billion, reallocating capital to higher-growth businesses.
Maintained active capital allocation with increased dividends and paused share buybacks post-Arcosa announcement.
Financial highlights
Q2 revenues reached $10.8 billion (+6% YoY); Adjusted EBITDA $2.63 billion (+7% YoY); net income $1.5 billion (+13% YoY); diluted EPS $2.21 (+14% YoY).
Adjusted EBITDA margin improved to 24.4% (+30bps YoY); net income margin 14.0% (+90bps YoY).
Depreciation, depletion, and amortization charges increased to $548 million due to acquisitions.
Interest expense rose to $220 million from higher gross debt; interest income declined to $22 million.
Other nonoperating income was $282 million, mainly from divestiture gains.
Outlook and guidance
Reaffirmed FY26 guidance: Adjusted EBITDA $8.1–$8.5 billion, net income $3.9–$4.1 billion, diluted EPS $5.60–$6.05.
Capital expenditure guidance updated to $2.7–$2.9 billion for 2026.
Positive demand outlook, especially in infrastructure and reindustrialization, with strong backlogs and bidding activity.
Expects continued margin expansion and robust performance into 2027.
2030 targets: 7–9% annual revenue growth, Adjusted EBITDA margin 22–24%, and Adjusted FCF conversion >100%.
Latest events from CRH
- Q2 saw 8% net income growth, 12% EBITDA rise, margin expansion, and raised FY24 guidance.CRH
H1 20248 Jul 2026 - Q3 saw 4% revenue and 12% EBITDA growth, strong M&A, and guidance reaffirmed.CRH
Q3 2024 TU8 Jul 2026 - $8.5B acquisition expands infrastructure leadership and targets $175M in synergies by year three.CRH
M&A announcement22 Jun 2026 - Q1 2026 saw 9% revenue growth, higher EBITDA, and reaffirmed guidance despite a wider net loss.CRH
Q1 202630 Apr 2026 - Record 2025 financials, double-digit EBITDA growth, and strong 2026 outlook on infrastructure demand.CRH
Q4 202511 Apr 2026 - Definitive proxy statement filed for shareholder voting under SEC regulations.CRH
Proxy filing27 Mar 2026 - Record financials, capital structure simplification, and strong governance drive 2026 agenda.CRH
Proxy filing27 Mar 2026 - Record financials, capital structure simplification, and key governance proposals for 2026 AGM.CRH
Proxy Filing13 Mar 2026 - Delisting and preference share cancellations aim to simplify capital structure and cut costs.CRH
Proxy Filing13 Mar 2026